Cholerae in the Americas region: An eradicated problem?  by Ramon-Pardo, P. et al.
e th In
d
5
S
K
R
t
H
T
K
s
i
r
r
s
l
p
a
C
b
c
A
S
a
s
i
f
a
m
t
W
E
i
p
r
a
h
m
t
c
g
d
5
C
P
1
2
(
a
S
t
t
t
N
f
p
o
b
a
i
t
c
a
s
l
f
p
w
a
t
n
l
M
c
t
n286 14
oi:10.1016/j.ijid.2010.02.2119
7.037
entinel surveillance of pandemic inﬂuenza A H1N1 in
enya in the period August — November 2009
. Achilla ∗, J. Majanja, M. Wadegu, W. Bulimo, D. Schnabel
USAMRU-K, Nairobi, Kenya
Background: In April 2009 a new variant of Inﬂuenza virus
hat was later declared a pandemic strain by the World
ealth Organization appeared on the American continent.
he ﬁrst case of the pandemic Inﬂuenza A H1N1 (pH1N1) in
enya was detected on 29th June 2009. The ﬁrst sentinel
urveillance case appeared in August 2009 and since then
ncreasing numbers of pH1N1 have been detected within the
egular sentinel surveillance network.
Methods: Eight public hospitals distributed across and
epresenting the entire country comprise our sentinel
urveillance sites. Nasopharyngeal swab specimens are col-
ected within 72 hours of symptom onset from consenting
atients presenting with inﬂuenza like illness. Specimens
re transported in liquid nitrogen to the National Inﬂuenza
enter. For all patient specimens, RNA is extracted followed
y reverse transcription and real time PCR assays. The spe-
iﬁc assays include screening for seasonal inﬂuenza A and B.
ll samples positive for Inﬂuenza A are further subtyped for
easonal H1, Seasonal H3 and pandemic H1.Results: In the four months from August to November,
total of 1329 samples were screened from the sentinel
urveillance network. Out of these 160 samples represent-
ng 12% were positive for pH1N1. Of these, 83(51.8%) were
t
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rom males and 120 (75%) of the patients were aged 5 years
nd below. The ages of the positive cases ranged from 9
onths to 53 years. No deaths were recorded in the coun-
ry during that period. 55% of the cases were found in the
estern region, 18% in the central region and 27% in the
astern/Coastal region. The epicenter of the outbreak was
n the Western region and this is reﬂected in the higher
ercentages of cases from that region. The Eastern/Coastal
egion receives many tourists from outside Africa and this
lso is reﬂected in the high percentages of cases reported
ere.
Conclusion: These results indicate that within a few
onths of introduction into Kenya, the pH1N1 quickly spread
hroughout the country. Most of the cases were seen among
hildren less than ﬁve years of age. The results show that
ender was not a risk factor in contracting the virus in Kenya.
oi:10.1016/j.ijid.2010.02.2120
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holerae in the Americas region: An eradicated problem?
. Ramon-Pardo1,∗, G. de Cosio1, M. Tato2, J. Mckenney1
Pan American Health Organization, Washington, DC, USA
Hospital Ramón y Cajal, Madrid, Spain
Background: The Pan American Health Organization
PAHO) proposed, in 1996, monitoring of resistance to
ntibiotics in the Americas Region. Thus organizing the
urveillance and Monitoring Network of Antimicrobial Resis-
ances countries committed to compiling information on
he identiﬁcation of isolated species and their sensitivity
o antibiotics. The protocols of surveillance used within the
etwork are consistent with the recommendations of WHO
or diarrheal diseases and respiratory tract infections. As
athogen responsible for severe disease and serious impact
n public health, Vibrio cholerae from human isolates has
een included among the surveyed pathogens. This study
ims at describing the capacity of the Network for detect-
ng V. cholerae outbreaks, by geographic distribution and
he trends of resistance to antibiotics.
Methods: Information about the serogroups and antimi-
robial susceptibility patterns of V. cholerae isolates were
nnually sent to the Network by the countries. Period of
tudy: 2000-2007. V. cholerae were identiﬁed by standard
aboratory methods. Serotype characterization was per-
ormed by serologic test (slide agglutination technique with
olyvalent antisera). Susceptibility to antimicrobial agents
as determined by the Kirby-Bauer disk diffusion method
nd interpreted ace recommended by the Clinical Labora-
ory Standards Institute.
Results: The total number of V. cholerae human isolates
otiﬁed during the study period was 2095. V. cholerae iso-
ates were only reported from Brazil, Cuba, El Salvador,
exico and Peru. V. cholerae serogroups O1 and non-O1
onstituted 179 (8.5%) and 1561 (74.5%) isolates, respec-
ively. During 2000, 2001 and 2002, 355 (17%) isolates were
otiﬁed without serotype characterization. Since 2003 all
he isolates were reported with the corresponding serotype
haracterization. For V. cholerae serogroup non-O1, the
esistance to ciproﬂoxacin and clorafenicol has remained
ow throughout these years. Nevertheless, the resistance
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to tetracycline, co-trimoxazole and erythromycin were vari-
able during the study period.
Conclusion: The number of isolates reported through the
Network was different from those published by the annual
summaries of cholera cases in WHO Weekly Epidemiologi-
cal Record. These discrepancies reﬂect the limitations in
surveillance and reporting systems. Data demonstrate that
choleare is present in the Americas Region with potential
for oubreaks. Laboratory surveillance should be integrated
in the national surveillance systems for accurate information
on outbreaks and burden of disease.
doi:10.1016/j.ijid.2010.02.2121
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Evidence for inﬂuenza A virus infection among patients
with respiratory tract infections in Nigeria
D. Ehichioya1,∗, R. Orenolu2, N. Gerloff3, S. De
Landtsheer4, A. Nasidi 5, T. Harry5, C. Muller3, S. Omilabu6
1 University of Lagos, Lagos, Nigeria
2 College of Medicine, University of Lagos, Idi-araba, P.M.B.
12003, Lagos, Lagos, Nigeria
3 Institute of Immunology, Department of the National
Health Laboratory, Luxembourg, Luxembourg
4 Institute of Immunology, Department of the National
Health Laboratory, Luxempourg, Luxembourg
5 Department of Public Health, Federal Ministry of Health„
Abuja, Nigeria
6 College of Medicine, University of Lagos, Idiaraba, P.M.B.
12003, Lagos, lagos, Nigeria
Background: Inﬂuenza viruses cause a highly contagious
acute respiratory disease that has resulted in epidemic and
pandemic in human populations over the years. In February
2006, poultry outbreaks of highly pathogenic avian inﬂuenza
A (H5N1) virus were conﬁrmed in Nigeria. A survey was
therefore set up to assess the role of inﬂuenza A virus in
several respiratory tract infections seen in some hospitals in
some hospitals in Lagos, Nigeria.
Methods: From April, 2008 to November 2009, sterile
swabs were used to swab the throat of 182 patients present-
ing with ﬂu-like symptoms. These patients had no knowledge
of exposure to any strain of inﬂuenza virus. Viral RNA were
eluted in transport media, extracted, transcribed and sub-
sequently, the polymerase chain reaction (PCR) was used to
amplify the complementary DNA.
Results: Seventy-eight (42.9%) tested positive for
inﬂuenza A virus: 53.8% and 46.2% were males and females
respectively. Overall, sampling was done in exactly the same
way for the wet (rainy) and dry seasons but 41 (52.6%) of the
positive patients were seen during the wet season while 37
(47.4%) were seen in the dry season. There was no statisti-
cally signiﬁcant difference between these values (p < 0.05).
Conclusion: The results shows inﬂuenza A virus plays
a signiﬁcant role in respiratory tract infections seen all
through the year. As diagnosis is hardly considered in the
management of these infections, it is advised that there
should be continued surveillance for inﬂuenza A infections
in humans. Seroprevalence investigations are also needed to
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ssess the risk associated with strains of inﬂuenza A virus,
iven that these viruses continue to circulate and evolve.
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elevance of infectious diseases in nephrology patients: A
etrospective single center Review of twenty renal biop-
ies
. Nguyen
Medical College of Georgia, Augusta, GA, USA
Background: Previous studies have examined the speciﬁc
ntities of renal pathology with bacterial/viral diseases.
ew have broadly studied infectious disease relevance
n patients affected by current immunosuppressive and
ytotoxic regimens. This retrospective was performed on
atients who had renal biopsy to assess renal dysfunctions.
Methods: Twenty transplant/non-transplant renal biop-
ies performed between January 1, 2009 and November 30,
009 were randomly reviewed. Concurrent infectious dis-
ases were identiﬁed.
Results: The biopsies belonged to 13 males & 6 females
7 cases: native biopsies & 13 cases: transplant biopsies). Of
he transplant cases, 4 cases showed concurrent infectious
iseases (23%). These cases included 2 cases (15%) from 1
atient with recurrent polyoma nephropathy, 2 cases (15%)
ith chronic allograft nephropathy (including 1 case with
yelonephritis/reﬂux nephropathy & 1 case with HIV having
cute tubular injury). The others, with no infectious compli-
ations, included 5 cases (38%) with delayed graft functions,
case (8%) with severe transplant glomerulopathy, and 1
ase (8%) with chronic allograft nephropathy/recurrence of
ocal proliferative lupus nephropathy. Of the native renal
ases, 2 cases (29%) were identiﬁed with infectious com-
lication. The cases include 1 case (14%) with HIV/HCV
& hypertension/chronic kidney disease/recurrent bacte-
ial pneumonia) and 1 case with urethral stenosis and
hronic pyelonephritis. The remaining cases without infec-
ions include recurrent focal segmental glomerulosclerosis
FSGS), 1 case (14%) with membranous lupus nephropathy,
case (14%) with focal proliferative nephritis & Henoch-
chonlein Purpura (HSP), 1 case with minimal change (14%)
n complete remission, and 1 hypertensive nephropathy
ase with thrombotic microangiopathy (TMA). With current
mmunosuppressive/cytotoxic drug regimen and careful fol-
ow up, few patients demonstrate concurrent infectious
isease. The few affected patients have history of urinary
ract infections associated urinary tract reﬂux/obstruction.
ecurrent polyoma viral nephropathy, seen in 2 cases of
pediatric patient, needed decreased immunosuppressive
egimen, altered cytotoxic therapy, and antiviral medica-
ion. One native kidney case of a patient with HIV/Hepatitis
infection showed recurrent pneumonia.
Conclusion: In this small review, most native & all
ecently transplanted specimens (within several months)
id not show systemic infections despite heavy initial dose
f cytotoxic/immunosuppressive regimen. Few affected
ases showed underlying chronic conditions such as HIV or
bstructive/reﬂux uropathy. Current regimens and clinical
anagement of medical renal diseases/renal transplants
